Spyre Therapeutics
Price & Volume
Stats
See more52W Range | $12.25-$75 |
Market Cap | $4.9B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$171.6M |
Diluted EPS | -$1.98 |
News
See moreYahoo Finance • 15 hours ago
Spyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock
Yahoo Finance • 2 days ago
Spyre Therapeutics launches $300M public stock offering
Yahoo Finance • 2 days ago
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
Yahoo Finance • 2 days ago
Spyre Therapeutics Flies On Takeda-Rivaling Ulcerative Colitis Results
About
CEO | Dr. Cameron Turtle DPHIL, Ph.D. |
Address | Building 23, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 102 |
